Randomization might, at first, sound like a scary word for health policy makers and professionals. They read medical journals and know from their training that randomized trials are scientifically rigorous designs to evaluate the impact of a program. But their first inclination might be to prefer to have the randomized trial in somebody else’s backyard. Randomization seems politically difficult. How to explain it to the people who will have to wait for the new intervention? Will it not create a backlash with the people who are randomly assigned to the control group?
March 20, 2013 - When starting a results-based financing program from scratch, can college professors be your best friend? World Bank team leader Gaston Sorgho thinks so.